sufficient number of patients for a statistically significant result to be possible. Without such a study the precise place of radiology in this poorly understood condition will never be clarified.
Tuberculosis in patients having dialysis
Patients having regular dialysis treatment have a lowered resistance to infection,' probably owing to a deficiency in cellular immunity. While this may be an advantage when they receive a kidney transplant, they are vulnerable to infection with the tubercle bacillus. Rates of infection up to 16 times that in the normal population have been reported in patients on dialysis,2 and in countries where tuberculosis is common in the general population the disease becomes a major problem in dialysis units. For example, 20 of the 329 patients treated by dialysis in Thessaloniki developed tuberculosis.3 On the other hand, when the prevalence of tuberculosis in the general population is low infection is correspondingly rare in patients on dialysis.4 Even in centres where tuberculosis has been common it has become less so with improved dialysis schedules.2
The most common presentation of tuberculosis in patients on dialysis is persistent fever without obvious cause, often accompanied by anorexia, nausea, vomiting, and consequent loss of weight. Similar non-specific symptoms are not uncommon in underdialysed patients, or the fever may be wrongly attributed to pyrogens in the dialyser; all too easily the correct diagnosis may be delayed. Nevertheless, there may be other presenting features, depending on the site of infection. Almost half of all patients have pulmonary or pleural infection or both, and another quarter have tuberculous lymphadenitis, usually cervical.3 Tuberculous osteitis is rare, as are miliary infection and meningitis. The symptoms of osteitis may be mistaken for renal osteodystrophy, when again diagnosis will often be delayed.
Even when the diagnosis is suspected clinical confirmation may often prove difficult. The erythrocyte sedimentation rate (ESR) is a useful pointer: though there is some rise in most patients on dialysis, the rise is much more striking in those with tuberculosis. Over three-quarters of the tuberculous patients had ESRs over 100 mm in one hour in a series reported from Tokyo,2 and values around 150 mm are not uncommon. There is usually a leucocytosis (> 10 x 109 1), and the concentration of C-reactive protein is usually raised; but these tests are non-specific. Unfortunately the reduced cellular immunity usually makes the tuberculin skin test result negative, even in fulminating cases.3 A chest radiograph is usually valuable in showing evidence of tuberculous infection, but bacteriological evidence of activity may be difficult to obtain, since culture of the sputum may be sterile and culture of pleural fluid may also be negative.3 The diagnosis of tuberculous lymphadenitis is readily made histologically. Tuberculous osteitis is difficult to diagnose: radiological changes occur late,3 and the diagnosis usually depends on biopsy or culture of drained pus. Miliary infection may also present difficulties in diagnosis. Changes were seen on the chest radiograph in only one-third of the cases described by Sasaki and his colleagues,2 and in two-thirds of their patients diagnosis was made only at necropsy.
Because of the difficulty in establishing the diagnosis bacteriologically and radiologically it may have to be established by a trial of antituberculous treatment2 3 in patients with persistent fever, leucocytosis, and raised sedimentation rate in whom other causes of fever have been excluded and in whom there has been no response to broad-spectrum antibiotic treatment.
The drugs used in treating tuberculosis in patients having dialysis are the same as those used in patients with normal renal function, though adjustments are usually necessary in dosage. Streptomycin should be reserved for patients who are acutely ill and need intravenous treatment. The dose is adjusted according to serum concentrations; the drug is removed by dialysis. Isoniazid, which is used in almost all cases, is predominantly eliminated from the body by hepatic acetylation to an inactive metabolite, and the drug and its metabolites are excreted by the kidney. Since acetylator status is not usually assessed the dose of isoniazid in patients having dialysis should not normally exceed 150 mg daily,5 though higher doses may be given if serum concentrations can be monitored. Rifampicin is also usually included in treatment. Since it is metabolised by the liver no adjustment of the usual daily dose of 450 to 600 mg (according to body weight) is necessary in renal failure. Ethambutol is usually added to the combination of isoniazid and rifampicin for the first two months of treatment to avoid the emergence of resistant strains. It is excreted largely unchanged by the kidney, and the dose should be reduced to 5 mg kg day in patients on dialysis.6
In active cases diagnosed bacteriologically, histologically, radiologically, or by an effective trial of treatment, triple treatment with isoniazid, rifampicin, and ethambutol should usually be given for two months, followed by a combination ofisoniazid and rifampicin for a further seven months.
Patients with evidence of previous tuberculosis should be given prophylactic chemotherapy with isoniazid as a routine after transplantation,7 and this prophylaxis should possibly be extended to patients on dialysis. Such a policy may be worthwhile in dialysis centres where tuberculosis has been a problem, but the case is correspondingly weaker when tuberculosis is rare. likely. Nevertheless, many patients believe that they are more susceptible to urinary tract infections in cold weather, so that we must ask whether there is any scientific justification for this belief. Stansfeld1 found that urinary tract infection occurred more commonly in children in the winter months, an observation recently confirmed by Elo et al.2 They showed a definite seasonal incidence in 992 verified episodes of urinary tract infection in boys and girls aged 2-15, with the overall incidence being highest in November and lowest in the summer months. Summer episodes, however, tended to be more severe. Seasonal variations were less definite in girls than boys, except in the teenage girls, in whom peak incidences occurred in March and September; in the boys a single peak incidence was recorded in July. The incidence of episodes of infection was related to the prevailing meteorological conditions: the lower the temperature and the higher the humidity, the greater their frequency. When weather conditions deviated from those expected for the time of year the monthly number of episodes of urinary tract infection increased appreciably.
Several explanations have been offered for this climatic variation. Upper respiratory tract infections may precede urinary tract infections3-5 and since coughs and colds are more common in the winter months the same would apply to urinary infections. Stansfeld,1 however, could not confirm any such association between infections of the respiratory and urinary tracts. The observation that unexpected weather conditions favour urinary tract infections may suggest that dressing in a fashion inappropriate for the weather conditions could be a key factor-some years ago there was a clinical impression that the introduction of the miniskirt had created a wave of urinary tract infections.
Even so, while the explanation for seasonal trends in urinary tract infection may be in doubt, the observations of Elo et a12 are relevant to prophylaxis. The simple message is dress for the weather and not for the season and be prepared. Or, as Angela Kilmartin6 put it, "If you decide to go to Greenland take some woollen combinations."
Stansfeld JM. Clinical The introduction of insulin in 1922 had dramatic effects: many lives were saved, and the quality of others was transformed. Since the development of long-term microvascular complications seems likely to be due to poor diabetic control, we must now attempt to improve it by finding new methods of treatment. Measurement of 24-hour blood-glucose profiles has shown considerable diurnal fluctuations of blood glucose concentrations-even with the best twice-daily regimens-and oscillations from severe hyperglycaemia to disabling hypoglycaemia present a daily hazard to diabetics treated with insulin. Recent years have therefore seen an intensive search for more physiological methods of delivering insulin.
Blood glucose control and microvascular complications-How good is the evidence that better control of the blood glucose would reduce the severity of microvascular complications? One recent comprehensive review1 concluded that tight diabetic control is indeed worthwhile, but only the previous year Ingelfinger2 had argued that the case was still highly contentious. Setting up appropriately designed studies is forbiddingly difficult, not least because of the diverse nature of tissues affected and the facts that (except for nephropathy) they may be affected singly or in combination and that basement membrane thickening is neither specific nor universal in diabetics-and even its exact relation to the microvascular complications is uncertain.
While neither complications nor basement membrane thickening are present in young diabetics at the onset of the disease,3 their prevalence increases with its duration; but a few patients (perhaps as many as one-fifth) are spared altogether.4 There is a genetic influence on the development of diabetic complications: thus diabetics who do not require insulin and also react positively to the chlorpropamide-alcohol-flush test seem to be protected from retinopathy when compared with those who do not flush.5 Retinopathy (or its absence) is remarkably similar in pairs of identical twins concordant for diabetes.6 Sex and racial differences have also been described in the prevalence of microvascular complications.7 No totallv convincing answer seems likely to be found to the problem, not least because any study would need to last a minimum of 10 years and because of the difficulties of assessing "control" over such a long period.
Nevertheless, many observations suggest that persistent hyperglycaemia is harmful. The effects of poor control are most obvious in pregnancy. Fetal mortality is higher in badly
